Helmholtz Gemeinschaft


PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice

PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
[img] Other (Supplementary Information)

Item Type:Article
Title:PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice
Creators Name:Messerschmidt, C. and Foddis, M. and Blumenau, S. and Müller, S. and Bentele, K. and Holtgrewe, M. and Kun-Rodrigues, C. and Alonso, I. and do Carmo Macario, M. and Morgadinho, A.S. and Velon, A.G. and Santo, G. and Santana, I. and Mönkäre, S. and Kuuluvainen, L. and Schleutker, J. and Pöyhönen, M. and Myllykangas, L. and Senatore, A. and Berchtold, D. and Winek, K. and Meisel, A. and Pavlovic, A. and Kostic, V. and Dobricic, V. and Lohmann, E. and Hanagasi, H. and Guven, G. and Bilgic, B. and Bras, J. and Guerreiro, R. and Beule, D. and Dirnagl, U. and Sassi, C.
Abstract:Recently, several genome-wide association studies identified PHACTR1 as key locus for five diverse vascular disorders: coronary artery disease, migraine, fibromuscular dysplasia, cervical artery dissection and hypertension. Although these represent significant risk factors or comorbidities for ischemic stroke, PHACTR1 role in brain small vessel ischemic disease and ischemic stroke most important survival mechanism, such as the recruitment of brain collateral arteries like posterior communicating arteries (PcomAs), remains unknown. Therefore, we applied exome and genome sequencing in a multi-ethnic cohort of 180 early-onset independent familial and apparently sporadic brain small vessel ischemic disease and CADASIL-like Caucasian patients from US, Portugal, Finland, Serbia and Turkey and in 2 C57BL/6J stroke mouse models (bilateral common carotid artery stenosis [BCCAS] and middle cerebral artery occlusion [MCAO]), characterized by different degrees of PcomAs patency. We report 3 very rare coding variants in the small vessel ischemic disease-CADASIL-like cohort (p.Glu198Gln, p.Arg204Gly, p.Val251Leu) and a stop-gain mutation (p.Gln273*) in one MCAO mouse. These coding variants do not cluster in PHACTR1 known pathogenic domains and are not likely to play a critical role in small vessel ischemic disease or brain collateral circulation. We also exclude the possibility that copy number variants (CNVs) or a variant enrichment in Phactr1 may be associated with PcomA recruitment in BCCAS mice or linked to diverse vascular traits (cerebral blood flow pre-surgery, PcomA size, leptomeningeal microcollateral length and junction density during brain hypoperfusion) in C57BL/6J mice, respectively. Genetic variability in PHACTR1 is not likely to be a common susceptibility factor influencing small vessel ischemic disease in patients and PcomA recruitment in C57BL/6J mice. Nonetheless, rare variants in PHACTR1 RPEL domains may influence the stroke outcome and are worth investigating in a larger cohort of small vessel ischemic disease patients, different ischemic stroke subtypes and with functional studies.
Keywords:Amino Acid Substitution, Brain Ischemia, Animal Disease Models, Microfilament Proteins, Missense Mutation, Stroke, Stroke / Pathology, Animals, Mice
Source:Scientific Reports
Publisher:Nature Publishing Group
Page Range:6072
Date:16 March 2021
Official Publication:https://doi.org/10.1038/s41598-021-84919-x
PubMed:View item in PubMed

Repository Staff Only: item control page


Downloads per month over past year

Open Access
MDC Library